Bupropion Sustained Release (SR) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) in Nondepressed Women.

Autor: Segraves, R. Taylor, Croft, Harry, Kavoussi, Richard, Ascher, John A., Batey, Sharyn R., Foster, Vicki J., Bolden-Watson, Carolyn, Metz, Alan
Předmět:
Zdroj: Journal of Sex & Marital Therapy; May-Jun2001, Vol. 27 Issue 3, p303-316, 14p
Abstrakt: This article describes the results of the first report of bupropion sustained release (SR) in nondepressed females with hypoactive sexual desire disorder (HSDD). Eligible females entered a 4-week, single-blind, placebo baseline phase . Subjects, all of whom did not respond to placebo, continued in a single-blind active treatment phase where they received bupropion SR for up to 8 additional weeks. We assessed HSDD by using investigator ratings of sexual desire and sexual functioning. Of the 51 evaluable subjects who entered the active treatment phase, 29% responded to treatment with bupropion SR. Bupropion SR was generally well tolerated. Pending the results of further study, bupropion SR may offer a treatment option for women with HSDD. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index